Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180927
What this trial is testing

DLL3 CAR-T Therapy Targeting Brain Tumors

Who this might be right for
Glioblastoma of Cerebellum
Shenzhen Geno-Immune Medical Institute 30
Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Not applicableEnded earlyNCT01281982
What this trial is testing

(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas

Who this might be right for
Low Grade GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 2
Not applicableLooking for participantsNCT06519682
What this trial is testing

A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)

Who this might be right for
High Grade GliomaReplication Repair Deficient
Daniel Morgenstern 20
Testing effectiveness (Phase 2)Study completedNCT03007823
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Who this might be right for
Melanoma
Fuda Cancer Hospital, Guangzhou 20
Testing effectiveness (Phase 2)UnknownNCT05827770
What this trial is testing

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Yong Chen 20
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Early research (Phase 1)Active Not RecruitingNCT05283109
What this trial is testing

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM

Who this might be right for
Glioma, Malignant
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 24
Testing effectiveness (Phase 2)Ended earlyNCT00104884
What this trial is testing

FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant MelanomaMelanoma
ECOG-ACRIN Cancer Research Group 4
Testing effectiveness (Phase 2)Study completedNCT03032484
What this trial is testing

TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma

Who this might be right for
Astrocytoma
The University of Texas Health Science Center at San Antonio 25
Testing effectiveness (Phase 2)Ended earlyNCT01857752
What this trial is testing

Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala

Who this might be right for
Retinoblastoma
Stanford University 3
Not applicableUnknownNCT05268952
What this trial is testing

Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Who this might be right for
Neuroendocrine Tumors
University Hospital, Antwerp 100
Not applicableStudy completedNCT01216267
What this trial is testing

Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples

Who this might be right for
Neuroendocrine Carcinoma (Carcinoid)
University of Western Ontario, Canada 200
Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Early research (Phase 1)UnknownNCT03582514
What this trial is testing

PreOperative Brain Irradiation in Glioblastoma

Who this might be right for
Glioblastoma Multiforme
The Christie NHS Foundation Trust 18
Testing effectiveness (Phase 2)Study completedNCT01989884
What this trial is testing

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Mario Negri Institute for Pharmacological Research 45
Not applicableStudy completedNCT07412158
What this trial is testing

Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)

Who this might be right for
Risk Grading SystemPheochromocytoma and Paraganglioma (PPGL)Quantitative Assessment
Peking University First Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01125800
What this trial is testing

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

Who this might be right for
MedulloblastomaRhabdomyosarcomaNeuroblastoma+3 more
Novartis Pharmaceuticals 76
Next Page